Thu, 18-Aug-2022
Thursday 28 Nov 2019 , 2:14 pm

Genetron Health Obtains Approval for Semiconductor-based NGS System GENETRON S5

GENETRON S5 can be used in early screening, diagnosis, treatment guidance and continuous monitoring. With the diagnostic assays developed by Genetron Health, gliomas, lung cancer, urothelial cancer, breast cancer and thyroid cancer can be detected more effectively.
By SIN Bureau
Share at:

Genetron Health has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The approval of a new desktop medium-throughput semiconductor-based next generation sequencing (NGS) system---GENETRON S5, showcases Genetron Health’s ongoing commitment to providing early screening, diagnosis and treatment recommendations, as well as continuous monitoring and care services.

“The approval of GENETRON S5 provides another excellent choice for clinical laboratories and adds another powerful instrument for the standardization of molecular diagnosis. GENETRON S5 will deliver high-quality laboratory testing while providing data for clinical use and precision medicine in a much faster manner,” said Sizhen Wang, Co-founder and CEO of Genetron Health.

GENETRON S5 can be used in early screening, diagnosis, treatment guidance and continuous monitoring. With the diagnostic assays developed by Genetron Health, gliomas, lung cancer, urothelial cancer, breast cancer and thyroid cancer can be detected more effectively.

“Since our establishment, Genetron Health has explored new technology and areas of application while adapting to changes in the industry landscape to improve precision medicine in China. Working with clinical experts and our strategic partners, we have made progress in the field of in vitro diagnostic devices (IVD). The efficiency and speed of GENETRON S5 makes it possible for clinical organizations to help many more cancer patients,” Wang added.




Neha Mule

Neha writes articles on sectors including medicine, food, materials, and science & technology. A qualified statistician, she has the ability to observe and analyze the trends in global markets and write compelling articles that help CXOs in decision making. She is a bookworm and loves to read fiction, lifestyle, science and technology. Neha comes with 6 years of experience in content writing and editing that involves blog writing, preparation of study materials and OERs.

More from Neha Mule

Related News